Pharmala Biotech Holdings Inc. (MDMA.CN)
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
0.16-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+55.0%
The outlook
Pharmala Biotech Holdings Inc. currently reads as bullish based on above its 50- & 200-day averages, 64% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range64% of the way from its 52-week low to high
Market cap
$16.9M
52-wk high
0.20
52-wk low
0.09
50-day avg
0.15
200-day avg
0.12
Trailing P/E
—